MARIAN FRIEDMAN: Open Payments
NPI 1649937020 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,075 in 182 payments from 17 companies in 2025. Trend: 2023 $2,690 · 2024 $1,758 · 2025 $3,075
Food & beverage: $3,070Education: $5
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 38 | $669 |
| Vanda Pharmaceuticals Inc. | 22 | $431 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $335 |
| Collegium Pharmaceutical, Inc. | 18 | $238 |
| ABBVIE INC. | 18 | $237 |
| Lundbeck LLC | 16 | $189 |
| Axsome Therapeutics, Inc. | 6 | $188 |
| Supernus Pharmaceuticals, Inc. | 9 | $135 |
| Janssen Pharmaceuticals, Inc | 6 | $100 |
| Tris Pharma Inc | 6 | $99 |
Products named: ARISTADA, CAPLYTA, FANAPT, Jornay PM, VRAYLAR, REXULTI, LYBALVI, Auvelity.
Industry payments across NC — which companies pay providers there.
